1262897-74-4
1262897-74-4
Chemical Structure
(2S)-Gemcitabine-13C,15N2 hydrochloride
- No. CAS: 1262897-74-4
- Formula:C813CH12ClF2N15N2O4
- Molecular Weight:302.64
IUPAC Name: 2-(methyl-d3)benzoic-3,4,5,6-d4 acid
InChIKey: OKKDEIYWILRZIA-YUECSCTESA-N
SMILES: FC1([C@]([15N]2[13C]([15N]=C(C=C2)N)=O)([H])O[C@@H]([C@H]1O)CO)F.Cl
Biological Activity: (2S)-Gemcitabine-13C,15N2 (hydrochloride) is the 13C and 15N labeled (2S)-Gemcitabine hydrochloride[1].
| Referencia número | Nombre del producto | Pureza | Descripciòn | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(2S)-Gemcitabine-13C,15N2 hydrochloride | 99.55% | (2S)-Gemcitabine-13C,15N2 (hydrochloride) is the 13C and 15N labeled (2S)-Gemcitabine hydrochloride. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Gemcitabine hydrochloride (Standard) | 99.94% | Gemcitabine (hydrochloride) (Standard) is the analytical standard of Gemcitabine (hydrochloride). This product is intended for research and analytical applications. Gemcitabine Hydrochloride (LY 188011 Hydrochloride) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine Hydrochloride inhibits DNA synthesis and repair, resulting in autophagyand apoptosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Gemcitabine-13C,15N2 hydrochloride | 99.55% | Gemcitabine-13C,15N2 (hydrochloride) is the 13C and 15N labeled Gemcitabine hydrochloride. Gemcitabine Hydrochloride (LY 188011 Hydrochloride) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine Hydrochloride inhibits DNA synthesis and repair, resulting in autophagyand apoptosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Gemcitabine hydrochloride | 99.89% | Gemcitabine Hydrochloride (LY 188011 Hydrochloride) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine Hydrochloride inhibits DNA synthesis and repair, resulting in autophagyand apoptosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
